Skip to content

The safety and efficacy of Remimazolam combined with Butorphanol in elderly patients undergoing painless gastroenteroscopy

The safety and efficacy of Remimazolam combined with Butorphanol in elderly patients undergoing painless gastroenteroscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070533
Enrollment
Unknown
Registered
2023-04-14
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical application of Remazolam

Interventions

C:Regular abstinence (Fasting for 8 hours and water deprivation for 4 hours)
S:Shortened abstinence (Fasting for 8 hours and water deprivation for 2 hours)

Sponsors

Shunde Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: The patients who are going to undergo painless gastroenteroscopy : unlimited for men and women, ASA grade I-II, aged 65-80 years, BMI 18-24kg /m^2

Exclusion criteria

Exclusion criteria: Acute gastrointestinal bleeding or shock; Acute onset of asthma; Acute upper respiratory tract infection; In need of a heart, liver or kidney transplant; Severe liver or kidney damage; Anemia or thrombocytopenia; Severe heart disease; Systolic blood pressure =180mmHg, diastolic blood pressure =110mmHg, heart rate =110 beats/min; Sleep apnea syndrome or pathological obesity; Suspected gastric retention or gastric emptying disorder; It is necessary to conduct examinations with large injurious stimulation (such as endoscopic ultrasound, polypectomy, etc.); Pregnant or lactating women; A history of drug and/or alcohol abuse; A history of long-term use of sedative and analgesic drugs; Mental system diseases; Or allergic to benzodiazepines or butorphanol

Design outcomes

Primary

MeasureTime frame
ED95;

Countries

China

Contacts

Public ContactYiwen Zhang

Shunde Hospital of Southern Medical y

ssss047@163.com+86 13794647543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026